How to write a patient case report
Open Access
- 1 October 2006
- journal article
- guideline
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 63 (19), 1888-1892
- https://doi.org/10.2146/ajhp060182
Abstract
Purpose. Guidelines for writing patient case reports, with a focus on medication-related reports, are provided. Summary. The format of a patient case report encompasses the following five sections: an abstract, an introduction and objective that contain a literature review, a description of the case report, a discussion that includes a detailed explanation of the literature review, a summary of the case, and a conclusion. The abstract of a patient case report should succinctly include the four sections of the main text of the report. The introduction section should provide the subject, purpose, and merit of the case report. It must explain why the case report is novel or merits review, and it should include a comprehensive literature review that corroborates the author’s claims. The case presentation section should describe the case in chronological order and in enough detail for the reader to establish his or her own conclusions about the case’s validity. The discussion section is the most important section of the case report. It ought to evaluate the patient case for accuracy, validity, and uniqueness; compare and contrast the case report with the published literature; derive new knowledge; summarize the essential features of the report; and draw recommendations. The conclusion section should be brief and provide a conclusion with evidence-based recommendations and applicability to practice. Conclusion. Patient case reports are valuable resources of new and unusual information that may lead to vital research.Keywords
This publication has 6 references indexed in Scilit:
- Anorexic Agents Aminorex, Fenfluramine, and Dexfenfluramine Inhibit Potassium Current in Rat Pulmonary Vascular Smooth Muscle and Cause Pulmonary VasoconstrictionCirculation, 1996
- Appetite-Suppressant Drugs and the Risk of Primary Pulmonary HypertensionThe New England Journal of Medicine, 1996
- The case report. I. Guidelines for preparationInternational Journal of Cardiology, 1983
- Pulmonary hypertension and fenfluramineBMJ, 1981
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981
- A preliminary communication on extensively disseminated Kaposiʼs sarcoma in young homosexual menThe American Journal of Dermatopathology, 1981